CAMBRIDGE, England & EDINBURGH, Scotland & GRASSE, France, October 21, 2024--(BUSINESS WIRE)--Axol Bioscience Ltd. (Axol), a leading induced pluripotent stem cell (iPSC) technology provider for drug ...

CAMBRIDGE, England & EDINBURGH, Scotland--(BUSINESS WIRE)--Axol Bioscience Ltd. (Axol), an established provider of iPSC-derived cells, media, and characterization services for life science discovery, ...

Axol Bioscience Ltd. (Axol), a leading pluripotent stem cell technology provider for drug discovery has signed an exclusive agreement with StrataStem to access and commercialize its extensive ...

CAMBRIDGE, England--(BUSINESS WIRE)--Axol Bioscience Ltd. (Axol), an established provider of iPSC-derived cells, media, and characterization services for life science discovery, today announced that ...

Axol Bioscience, a biotechnology company, specialising in the use of stem cell technology to manufacture disease relevant cell based assay systems to the drug discovery industry, has announced Prof ...

Horizon Discovery Group said today it will partner with Axol Bioscience to generate genomically modified and differentiated induced pluripotent stem cells (iPSCs). The value of the collaboration and ...

Chesterford Research Park has announced Axol’s arrival at the Park. Previously based at Babraham Research Campus, Axol’s move to Chesterford has been necessitated by the organic growth of its business ...

Axol Bioscience Ltd. (Axol), a leading induced pluripotent stem cell (iPSC) technology provider for drug discovery, today announced it has fully acquired Phenocell SAS, a pioneer in iPSC-based ...